thumbnail
Facilities & CapacityResilience cites GLP-1 demand in $225m+ fill/finish expansionResilience cites GLP-1 demand in $225m+ fill/finish expansion
Plans to expand National Resilience’s drug product manufacturing capabilities will support the strained capacity demands for GLP-1 blockbusters.